Navigation Links
Artemis Health Licenses Prenatal Cell-Free DNA Analysis Technology from Stanford University
Date:1/27/2009

-- New Technology May Allow Development of Accurate Blood Test for Common Genetic Disorders Early in Pregnancy --

MENLO PARK, Calif., Jan. 27 /PRNewswire/ -- Artemis Health Inc., a privately-held company dedicated to the development of non-invasive prenatal diagnostic tests, today announced that it has acquired a co-exclusive worldwide license from Stanford University to develop cell-free fetal DNA prenatal diagnostic tests based on pioneering research from the lab of Stephen Quake, Ph.D., co-chair of the department of bioengineering and Howard Hughes Medical Institute investigator. The license expands Artemis' clinical and research program and will allow the company to develop a non-invasive prenatal blood test that accurately predicts chromosomal and genetic disorders.

"We are thrilled to expand our proprietary prenatal diagnostic platform focused on intact fetal cells to include Dr. Quake's pioneering cell-free fetal DNA analysis," said Lissa Goldenstein, president and chief executive officer of Artemis Health. "We now have two complementary approaches that provide access to vital information found only in fetal DNA, which circulates in the maternal bloodstream. We believe that working in parallel, we will be able to develop non-invasive, safe and effective prenatal blood tests that accurately diagnose genetic disorders without the need for invasive tests like amniocentesis and chorionic villus sampling."

This license broadens the research and development programs at Artemis, which have been based primarily on the pioneering work of Dr. Diana Bianchi for the isolation of intact fetal cells from maternal blood for advanced genetic analysis. Under the terms of the agreement, Artemis received a co-exclusive worldwide license to a suite of intellectual property based on Dr. Quake's groundbreaking cell-free fetal DNA analysis research in the field of prenatal diagnostics which was featured in the
'/>"/>

SOURCE Artemis Health Inc.
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3

Related biology technology :

1. Exelixis Sells 80% Stake in Artemis to Taconic
2. Hearing Scheduled in the Delaware Court of Chancery for August 27, 2007 to Establish the Valid Approval and Consummation of the Merger Between PharmAthene, Inc. and Healthcare Acquisition Corp.
3. Research Triangle Area Health Care Collaborative Launches Bridges to Excellence(R) Initiative to Improve Quality and Lower Costs
4. Healthcare Technologies Calls for a Shareholders Meeting to Approve the Nexgen Biofuels Transaction
5. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
6. Ohio Ranks Best in the Midwest for Venture Capital Investment in Health Care Bioscience Industry
7. Proceedings to Affirm Merger Between PharmAthene and Healthcare Acquisition Corp Initiated in Delaware Chancery Court
8. InterCure and Omron Healthcare (UK) Ltd. Announce Marketing Collaboration for Hypertension Market in United Kingdom
9. Apria Healthcare Chooses Masimo SET Pulse Oximetry for Use in the Companys Home Health Care Business
10. NuVasive to Present at Thomas Weisel Partners Healthcare Conference
11. Monogram Biosciences to Present at the Thomas Weisel Partners Healthcare Conference 2007

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)... , , , , , , , ... , AUDIO: , A team of scientists ...rsity of Arizona, Cold Spring Harbor Laboratory an...e DNA of corn. The... , , Click h... , , , , , , , ...
(Date:11/20/2009)... , SAN DIEGO, Nov. 20 Veridiam ...rd in the mid-size company category at the 2009 Wo...d by the San Diego Society for Human Resources Man...uman resources practices. ,, Veridiam was one o...ee-nominated companies, honored at the recent awar...
(Date:11/20/2009)... , ROCKVILLE, Md., Nov. 20 /PRNewswire-FirstC...nced that it has priced an underwritten public off... price to the public of $3.30 per share. The appr...ting the underwriting discounts and commissions, w...rials of our VLP-based vaccines, internal research...
(Date:11/20/2009)... , SEATTLE, Nov. 20 /PRNewswire-FirstCall/ ...CTIC) announced today that the Ninth Circuit Court...nd ruled that CTI should be allowed to pursue all ...case back to the District Court for trial. CTI fi...er third-party reimbursement consultant for CTI,s ...
Breaking Biology Technology:Amaizing: Corn genome decoded 2Amaizing: Corn genome decoded 3Amaizing: Corn genome decoded 4Veridiam Wins Workplace Excellence Crystal Award in Mid-Size Company Category 2Novavax Prices Public Offering of Common Stock 2Cell Therapeutics Wins Federal Appeal to Pursue $22.8 Million Claim Against The Lash Group 2
...database of biotech contract service providers, I...tiative to grow the life sciences, has released an... pharmaceutical and biotechnology industries,holdi...e sciences growth.,In addition, the initiative has...adslinx.com -- offering a searchable database of,...
...MBF Healthcare,Acquisition Corp. (Amex: MBH ), a ...y, announced today that it and Critical Homecare,S...g provider of,comprehensive home infusion therapy ...present on Tuesday, March 18, 2008 at the Lehman B...ce in Miami, Florida. On February,6, 2008, MBH sig...
...rmacopeia,(Nasdaq: PCOP ), an innovator in the di...erapeutics, today announced advancements for two m...Vice President, Clinical and,Regulatory Affairs, h...l,and Regulatory Affairs, and the role of S. David...and Preclinical Chemical Development, has been,exp...
Other Biology Technology:BioCrossroads Launches www.biocrossroadslinx.com and Releases Report on Biopharma Discovery and Development Contract Services 2BioCrossroads Launches www.biocrossroadslinx.com and Releases Report on Biopharma Discovery and Development Contract Services 3BioCrossroads Launches www.biocrossroadslinx.com and Releases Report on Biopharma Discovery and Development Contract Services 4MBF Healthcare Acquisition Corp. and Critical Homecare Solutions Holdings, Inc. to Present at Lehman Brothers Eleventh Annual Global Healthcare Conference 2MBF Healthcare Acquisition Corp. and Critical Homecare Solutions Holdings, Inc. to Present at Lehman Brothers Eleventh Annual Global Healthcare Conference 3Pharmacopeia Announces Management Team Changes 2Pharmacopeia Announces Management Team Changes 3Pharmacopeia Announces Management Team Changes 4Pharmacopeia Announces Management Team Changes 5
(Date:11/23/2009)...re a nasty business, posing dangers to human healt...sity is launching a new project with funding from ...t targets the fat and grease that contribute to mi...n planners new tools to further reduce the risk of...anitary" sewer systems, as opposed to "combined" s...
(Date:11/22/2009)...ldren exposed prenatally to tobacco smoke and duri... for ADHD, according to research done at Cincinnat...y estimates that up to 35 percent of ADHD cases in...duced by eliminating both of these environmental e...children , "Tobacco and lead exposure each have...
(Date:11/22/2009)...ted gene deletion can increase the likelihood of i...ntation, an international team of researchers repo...ture Genetics . When the gene, called UGT2B17, is ... recipient,s, transplants have a significantly gre...versus-host disease, in which immune cells from th...
Breaking Biology News(10 mins):Lose the fat: Targeting grease to curtail sewer overflows 2Exposure to lead, tobacco smoke raises risk of ADHD 2Gene mismatch influences success of bone marrow transplants 2Gene mismatch influences success of bone marrow transplants 3Gene mismatch influences success of bone marrow transplants 4Americans Attitudes On Economic Issues Have Shifted Per Franklin 26 Marshall College Poll With Hearst Television 58253 1Americans Attitudes On Economic Issues Have Shifted Per Franklin 26 Marshall College Poll With Hearst Television 58253 2Americans Attitudes On Economic Issues Have Shifted Per Franklin 26 Marshall College Poll With Hearst Television 58253 3Americans Attitudes On Economic Issues Have Shifted Per Franklin 26 Marshall College Poll With Hearst Television 58253 4China Biologic Products Enters into a Strategic Research and Development Agreement with IBT of CAMS 14257 1China Biologic Products Enters into a Strategic Research and Development Agreement with IBT of CAMS 14257 2China Biologic Products Enters into a Strategic Research and Development Agreement with IBT of CAMS 14257 3China Biologic Products Enters into a Strategic Research and Development Agreement with IBT of CAMS 14257 4Amylin and Lilly to Present More than 20 Studies for Exenatide at EASD 2009 14255 1Amylin and Lilly to Present More than 20 Studies for Exenatide at EASD 2009 14255 2Amylin and Lilly to Present More than 20 Studies for Exenatide at EASD 2009 14255 3Amylin and Lilly to Present More than 20 Studies for Exenatide at EASD 2009 14255 4Amylin and Lilly to Present More than 20 Studies for Exenatide at EASD 2009 14255 5Amylin and Lilly to Present More than 20 Studies for Exenatide at EASD 2009 14255 6Amylin and Lilly to Present More than 20 Studies for Exenatide at EASD 2009 14255 7
...TON Members of the public can send their names ar...ssion dedicated to understanding the effects of pa...y on our climate. , The "Send Your Name Around th... the science mission and place their names in orbi...nts can submit their information, is located at: ,...
..., Sept. 25, 2008 Noted energy and environment exp...ries at the University of Houston, addressing the ...or the Houston area. , "The Science and Policy ... to the public and is held from 5:45 to 7:15 p.m. ...week and is being held in room 101 of the Cameron ...
...er managing environmental issues during deployment... advantages that will help in combat and post-conf..., according to a RAND Corporation study issued tod...ually given environmental concerns high priority d...onditions can have on troop health, safety and sec...
Other Biology News:Send your name around the Earth on NASA'S Glory mission 2Experts discuss climate change during UH lecture series 2Army can boost mission success by better managing 2Army can boost mission success by better managing 3Army can boost mission success by better managing 4
...iety of solvent vapors that can contaminate and de...ion flask (GCF400) allows for the collection of li...Rapid cooling time minimizes waiting period., , ...es , -50?C Temerature for trapping a wide vari...
...ine/threonine phosphatase isolated from human red ...60kDa (A) and 36kDa (C) subunits. It has the abili...se kinase. With its 3638kDa catalytic subunit, PPa... a regulatory role in DNA replication, transcripti...
...canning multimode reader with built-in dispenser a... offers superior flexibility and reliability for d...s unlimited wavelength selection for fluorescence ...ric assays and a dispenser for optimization of kin...
...iety of solvent vapors that can contaminate and de...ion flask (GCF400) allows for the collection of li...Rapid cooling time minimizes waiting period., U... solvents , Digital Display of temperature ...
Biology Products: